Kymera Therapeutics, Inc.
KYMR
Clasificación en acciones
#2147
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Precio por acción
$113.68
Última sincronización: 2026-10-21
Capitalización bursátil
$9.35B
Cambio (1 día)
0.19%
Cambio (1 año)
103.73%
País
US
Comercio Kymera Therapeutics, Inc. (KYMR)
Categoría
Healthcare
Historial del precio de la acción de Kymera Therapeutics, Inc. (KYMR)
Precio más alto de cierre: $109.14 el 2026-10-01
Precio más bajo de cierre: $31.67 el 2020-08-01
Precio más bajo de cierre: $31.67 el 2020-08-01
Historial del precio de la acción de Kymera Therapeutics, Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 12.05% |
| 2025 | 87.59% |
| 2024 | 77.01% |
| 2023 | -11.39% |
| 2022 | -52.05% |
| 2021 | -12.80% |
| 2020 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $765.49 | 8.80% |
CH
|
